Brief: Assertio Holdings To Acquire Spectrum Pharmaceuticals In All Stock And CVR Transaction

Spectrum Pharmaceuticals

25/04/2023 12:48

April 25 (Reuters) - Assertio Holdings Inc  ASRT.O :
    * ASSERTIO HOLDINGS, INC. TO ACQUIRE SPECTRUM
PHARMACEUTICALS,
INC. IN ALL STOCK AND CVR TRANSACTION
    * ASSERTIO HOLDINGS - SPECTRUM STOCKHOLDERS WILL RECEIVE
UPFRONT
CONSIDERATION OF 0.1783 ASRT SHARES PER SPPI SHARE ($1.14 PER
SHARE)
    * ASSERTIO HOLDINGS - SPECTRUM STOCKHOLDERS WILL ALSO
RECEIVE ONE
CVR FOR TOTAL POTENTIAL CONSIDERATION OF UP TO $1.34 PER SHARE
    * ASSERTIO HOLDINGS - TRANSACTION EXPECTED TO BE ACCRETIVE
TO
ASSERTIO’S ADJUSTED EPS AND OPERATING CASH FLOW IN 2024
    * ASSERTIO HOLDINGS - FOLLOWING THE CLOSE OF THE
TRANSACTION,
ASSERTIO STOCKHOLDERS WILL OWN APPROXIMATELY 65% OF THE COMBINED
COMPANY
    * ASSERTIO HOLDINGS - FOLLOWING THE CLOSE OF THE
TRANSACTION,
SPECTRUM STOCKHOLDERS WILL OWN APPROXIMATELY 35%, ON A FULLY
DILUTED BASIS

Source text for Eikon:  ID:nGNXZfWcQ 
Further company coverage:  ASRT.O